Presentations

08:00

Australian outcomes for hypothermic machine perfusion in heart transplant recipients since 2021: A retrospective, single centre study

Natasha Dehghani (AU)

Bio Abstract

08:10

Validation of a two-threshold algorithm (2TA) combining donor-derived cell-free DNA (dd-cfDNA) fraction and quantity to detect Heart transplant rejection defined by gene expression changes

Cesar Escrig (CH)

Bio Abstract

08:20

Sustained Myocardial Viability Following a 32-Hour Ex Vivo Preservation: The Impact of Intermittent Cold Storage and 24-Hour Normothermic Perfusion

Syed Raza (US)

Bio Abstract

08:27

Does significant tricuspid regurgitation early after heart transplantation resolve?

Sakae Takenaka (US)

Bio Abstract

08:34

Long term rejection outcomes in donation after circulatory death heart transplantation

Katherine Wang (AU)

Bio

08:41

Investigation of the relationship between antibody-mediated rejection and serum interleukin-40 level in heart transplant patients

Bilkay Basturk (TR)

Bio Abstract

08:46

Antibody mediated rejection is equivalent in donation after circulatory death and brain death donor cohorts: a ten-year Australian analysis

Campbell MacLean (AU)

Bio Abstract